Four-protein model for predicting prognostic risk of lung cancer

Front Med. 2022 Aug;16(4):618-626. doi: 10.1007/s11684-021-0867-0. Epub 2022 Mar 9.

Abstract

Patients with lung cancer at the same stage may have markedly different overall outcome and a lack of specific biomarker to predict lung cancer outcome. Heat-shock protein 90 β (HSP90β) is overexpressed in various tumor cells. In this study, the ELISA results of HSP90β combined with CEA, CA125, and CYFRA21-1 were used to construct a recursive partitioning decision tree model to establish a four-protein diagnostic model and predict the survival of patients with lung cancer. Survival analysis showed that the recursive partitioning decision tree could distinguish the prognosis between high- and low-risk groups. Results suggested that the joint detection of HSP90β, CEA, CA125, and CYFRA21-1 in the peripheral blood of patients with lung cancer is plausible for early diagnosis and prognosis prediction of lung cancer.

Keywords: HSP90β; decision tree model; lung cancer; prognosis.

MeSH terms

  • Antigens, Neoplasm
  • Biomarkers, Tumor
  • CA-125 Antigen
  • Carcinoembryonic Antigen
  • Carcinoma, Non-Small-Cell Lung* / pathology
  • Humans
  • Keratin-19
  • Lung Neoplasms*
  • Prognosis

Substances

  • Antigens, Neoplasm
  • Biomarkers, Tumor
  • CA-125 Antigen
  • Carcinoembryonic Antigen
  • Keratin-19
  • antigen CYFRA21.1